Successful eradication of established peritoneal ovarian tumors in SCID-beige mice following adoptive transfer of T cells genetically targeted to the MUC16 antigen

被引：0
|
作者：
Chekmasova, Alena A.
Thapi, Dharmarao
Nikhamin, Yan
Park, Kay J.
Spriggs, David R.
Brentjens, Renier J.
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-1940
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1940
引用
收藏
页数：3
相关论文
共 7 条
  • [1] Successful Eradication of Established Peritoneal Ovarian Tumors in SCID-Beige Mice following Adoptive Transfer of T Cells Genetically Targeted to the MUC16 Antigen
    Chekmasova, Alena A.
    Rao, Thapi D.
    Nikhamin, Yan
    Park, Kay J.
    Levine, Douglas A.
    Spriggs, David R.
    Brentjens, Renier J.
    CLINICAL CANCER RESEARCH, 2010, 16 (14) : 3594 - 3606
  • [2] Genetically Modified Human T Cells Targeted to Retained Epitopes of the MUC16 Antigen Are Functional and Mediate Lysis of Ovarian Tumor Cell Lines
    Chekmasova, Alena A.
    Nikhamin, Yan
    Thapi, Dharmarao
    Spriggs, David R.
    Brentjens, Renier J.
    MOLECULAR THERAPY, 2009, 17 : S213 - S214
  • [3] Trafficking of CAR-Engineered Human T Cells Following Regional or Systemic Adoptive Transfer in SCID Beige Mice
    Parente-Pereira, Ana Caterina
    Burnet, Jerome
    Ellison, David
    Foster, Julie
    Davies, David Marc
    van der Stegen, Sjoukje
    Burbridge, Sophie
    Chiapero-Stanke, Laura
    Wilkie, Scott
    Mather, Stephen
    Maher, John
    JOURNAL OF CLINICAL IMMUNOLOGY, 2011, 31 (04) : 710 - 718
  • [4] Trafficking of CAR-Engineered Human T Cells Following Regional or Systemic Adoptive Transfer in SCID Beige Mice
    Ana Caterina Parente-Pereira
    Jerome Burnet
    David Ellison
    Julie Foster
    David Marc Davies
    Sjoukje van der Stegen
    Sophie Burbridge
    Laura Chiapero-Stanke
    Scott Wilkie
    Stephen Mather
    John Maher
    Journal of Clinical Immunology, 2011, 31 : 710 - 718
  • [5] Long term survival of SCID-beige mice bearing Raji cell tumors after intravenous treatment with human T cells genetically modified to recognize the CD19 antigen.
    Brentjens, RJ
    Gong, MC
    Latouche, JB
    Riviere, I
    Sadelain, M
    BLOOD, 2001, 98 (11) : 694A - 694A
  • [6] Effect of modulation of the hostile tumor microenvironment through adoptive transfer of IL-12 expressing MUC-16 targeted T cells on ovarian tumors in vivo
    Chekmasova, Alena A.
    Sandadi, Samith
    Spriggs, David R.
    Brentjens, Renier J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Antigen specific elimination of established tumor metastases in mice following adoptive immunotherapy with genetically modified murine T-cells expressing a chimeric T-cell receptor (chTCR) specific for p185HER2.
    Yang, JM
    Friedman, MS
    Fuller, J
    Braun, T
    Eshhar, Z
    Mule, JJ
    McDonagh, KT
    BLOOD, 2000, 96 (11) : 551A - +
1